Nicotinic receptors and alcohol reinforcement
烟碱受体和酒精强化
基本信息
- 批准号:9176577
- 负责人:
- 金额:$ 38.14万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-07-15 至 2021-03-31
- 项目状态:已结题
- 来源:
- 关键词:15q25AgonistAlcohol consumptionAlcohol dependenceAlcohol withdrawal syndromeAlcoholismAlcoholsAttenuatedBackBehavioralBiological AssayCell NucleusCellsCessation of lifeChantixChromosomesConsumptionControl AnimalCoupledDevelopmentDiseaseElectrophysiology (science)Gene TransferGenesGoalsHabenulaHabitsHealthHumanHuman GenomeIndividualIntakeKnock-in MouseKnockout MiceLaboratoriesMarketingMedialMediatingMidbrain structureMolecular GeneticsMusMutant Strains MiceNeuronsNicotineNicotinic ReceptorsNicotinyl AlcoholPathway interactionsPlayPrevalenceProceduresPropertyRattusReceptor SignalingResearchRewardsRiskRodentRoleRubidiumSelf StimulationSignal TransductionSliceSmokerSynapsesSystemTechniquesTechnologyTestingTherapeutic AgentsTimeTobaccoTobacco DependenceTobacco smokeTobacco smokingUnited StatesVariantVirusWhole-Cell Recordingsaddictionalcohol effectalcohol reinforcementdesigner receptors exclusively activated by designer drugsdopamine systemgenome wide association studyinnovationinsightinterdisciplinary approachinterpeduncular nucleusknock-downnon-smokernoveloptogeneticsprematureprogramspromoterreceptorreceptor functionrecombinaseresponserisk variantsmoking cessationtransmission processvareniclinevector
项目摘要
PROJECT SUMMARY
This application is submitted in response to PA-13-194: Mechanisms of alcohol and nicotine co-addiction.
Allelic variation in CHRNA5, the gene encoding the α5 nicotinic acetylcholine receptor (nAChR) subunit,
increases vulnerability to alcohol and tobacco dependence. Here, we will use cutting-edge molecular, genetic
and behavioral techniques to investigate the role for α5* nAChRs, particularly those in the medial habenula
(MHb)-interpeduncular nucleus (IPN) pathway where α5* nAChRs are densely expressed, in regulating the
motivational properties of alcohol. In Specific Aim I, we will assess alcohol drinking in two lines of mice with
deficient α5* nAChR signaling: α5 subunit knockout mice and “humanized” knock-in mice in which the α5
nAChR subunit gene has been genetically modified to express the major risk allele for tobacco and alcohol
dependence in humans. Second, we will use the intracranial self-stimulation (ICSS) procedure to assess the
rewarding and aversive effects of alcohol in these lines of mutant mice. We predict that alcohol intake will be
increased, and aversive effects of alcohol decreased, in mice with deficient α5* nAChR signaling. In Specific
Aim II, we will investigate the effects of alcohol on the MHb-IPN system. First, we will use optogenetics coupled
with electrophysiological recordings to examine the effects of alcohol on excitatory and inhibitory transmission
at the MHb-IPN synapse and determine the role for α5* nAChRs in these effects. Second, we will use rubidium
efflux assays to determine the effects of alcohol drinking on the activity of α5* nAChRs in the MHb-IPN system.
We predict that alcohol stimulates excitatory MHb inputs to IPN – an “aversion” signal – and that this effect is
attenuated by deficient α5* nAChR signaling. We further predict that prolonged alcohol intake results in
diminished activity of α5* nAChRs in MHb-IPN system, which may contribute to the development of the alcohol
drinking habit. In Specific Aim III, we will investigate the involvement of the MHb-IPN system, and α5* nAChRs
in this system, in regulating alcohol drinking. First, we will use an elegant Cre recombinase-dependent
chemogenetics (DREADD) approach to stimulate or inhibit neurons in the MHb-IPN system, or more
selectively only those MHb-IPN neurons that express α5* nAChRs, and examine effects on alcohol drinking.
Second, we will use virus-mediated gene transfer to re-express otherwise absent α5 nAChR subunits in MHb
or IPN neurons of the α5 KO mice and examine the effects on alcohol drinking in these mice. We predict that
the MHb-IPN system, and α5* nAChRs in this system, play a key role in regulating alcohol intake. This
innovative program of research may yield novel insights into the mechanisms of alcohol dependence that
supports development of entirely new classes of therapeutic agents.
项目摘要
本申请是根据PA-13-194:酒精和尼古丁共同成瘾的机制提交的。
CHRNA 5(编码α5尼古丁乙酰胆碱受体(nAChR)亚基的基因)的等位基因变异,
增加对酒精和烟草依赖的脆弱性。在这里,我们将使用尖端的分子,遗传
和行为技术来研究α5* nAChRs的作用,特别是内侧缰核中的作用。
(MHb)-脚间核(IPN)途径,其中α5* nAChR密集表达,在调节
酒精的动机特性在具体目标I中,我们将评估两种小鼠的饮酒情况,
缺乏α5* nAChR信号传导:α5亚基敲除小鼠和“人源化”敲入小鼠,其中α5亚基敲除小鼠和“人源化”敲入小鼠的α5* nAChR信号传导缺失。
nAChR亚基基因已被遗传修饰,以表达烟草和酒精的主要风险等位基因
人类的依赖。其次,我们将使用颅内自刺激(ICSS)程序来评估
酒精在这些突变小鼠品系中的奖励和厌恶作用。我们预测,酒精摄入量将
在α5* nAChR信号传导缺陷的小鼠中,酒精的抑制作用增加,而酒精的抑制作用减少。在特定
目的二,考察乙醇对MHb-IPN体系的影响。首先,我们将使用光遗传学结合
用电生理记录来检查酒精对兴奋性和抑制性传递的影响
在MHb-IPN突触,并确定α5* nAChR在这些影响中的作用。第二,我们将使用铷
外排试验,以确定饮酒对MHb-IPN系统中α5* nAChR活性的影响。
我们预测,酒精刺激兴奋性MHb输入到IPN -一个“厌恶”信号-这种效应是
通过缺乏α5* nAChR信号传导而减弱。我们进一步预测,长期饮酒会导致
MHb-IPN系统中α5* nAChRs的活性降低,这可能有助于酒精的发展
饮酒习惯在具体目标III中,我们将研究MHb-IPN系统的参与,以及α5* nAChRs
在这个系统中,在调节饮酒方面。首先,我们将使用一个优雅的Cre重组酶依赖
化学遗传学(DREADD)方法来刺激或抑制MHb-IPN系统中的神经元,或更多
选择性地仅那些表达α5* nAChR的MHb-IPN神经元,并检查对饮酒的影响。
其次,我们将使用病毒介导的基因转移来重新表达MHb中原本缺失的α5 nAChR亚基
或IPN神经元的α5基因敲除小鼠,并检查对这些小鼠饮酒的影响。我们预测
MHb-IPN系统和该系统中的α5* nAChR在调节酒精摄入中起关键作用。这
创新的研究计划可能会对酒精依赖的机制产生新的见解,
支持开发全新类别的治疗剂。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Paul J. Kenny其他文献
The single-cell opioid responses in the context of HIV (SCORCH) consortium
人类免疫缺陷病毒(HIV)背景下的单细胞阿片类药物反应(SCORCH)联盟
- DOI:
10.1038/s41380-024-02620-7 - 发表时间:
2024-06-15 - 期刊:
- 影响因子:10.100
- 作者:
Seth A. Ament;Rianne R. Campbell;Mary Kay Lobo;Joseph P. Receveur;Kriti Agrawal;Alejandra Borjabad;Siddappa N. Byrareddy;Linda Chang;Declan Clarke;Prashant Emani;Dana Gabuzda;Kyle J. Gaulton;Michelle Giglio;Federico M. Giorgi;Busra Gok;Chittibabu Guda;Eran Hadas;Brian R. Herb;Wen Hu;Anita Huttner;Mohammad R. Ishmam;Michelle M. Jacobs;Jennifer Kelschenbach;Dong-Wook Kim;Cheyu Lee;Shuhui Liu;Xiaokun Liu;Bertha K. Madras;Anup A. Mahurkar;Deborah C. Mash;Eran A. Mukamel;Meng Niu;Richard M. O’Connor;Chelsea M. Pagan;Alina P. S. Pang;Piya Pillai;Vez Repunte-Canonigo;W. Brad Ruzicka;Jay Stanley;Timothy Tickle;Shang-Yi A. Tsai;Allen Wang;Lauren Wills;Alyssa M. Wilson;Susan N. Wright;Siwei Xu;Junchen Yang;Maryam Zand;Le Zhang;Jing Zhang;Schahram Akbarian;Shilpa Buch;Christine S. Cheng;Michael J. Corley;Howard S. Fox;Mark Gerstein;Suryaram Gummuluru;Myriam Heiman;Ya-Chi Ho;Manolis Kellis;Paul J. Kenny;Yuval Kluger;Teresa A. Milner;David J. Moore;Susan Morgello;Lishomwa C. Ndhlovu;Tariq M. Rana;Pietro Paolo Sanna;John S. Satterlee;Nenad Sestan;Stephen A. Spector;Serena Spudich;Hagen U. Tilgner;David J. Volsky;Owen R. White;Dionne W. Williams;Hongkui Zeng - 通讯作者:
Hongkui Zeng
Binge drinking and brain stress systems
酗酒和大脑压力系统
- DOI:
10.1038/520168a - 发表时间:
2015-04-08 - 期刊:
- 影响因子:48.500
- 作者:
Richard M. O'Connor;Paul J. Kenny - 通讯作者:
Paul J. Kenny
Binge drinking and brain stress systems
酗酒和大脑压力系统
- DOI:
10.1038/520168a - 发表时间:
2015-04-08 - 期刊:
- 影响因子:48.500
- 作者:
Richard M. O'Connor;Paul J. Kenny - 通讯作者:
Paul J. Kenny
Chronic stress drives depression by disrupting cellular housekeeping
慢性应激通过破坏细胞的内环境稳定来引发抑郁症。
- DOI:
10.1038/d41586-025-00910-w - 发表时间:
2025-04-09 - 期刊:
- 影响因子:48.500
- 作者:
Alberto Corona;Paul J. Kenny - 通讯作者:
Paul J. Kenny
Paul J. Kenny的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Paul J. Kenny', 18)}}的其他基金
Single cell transcriptomic and epigenomic changes during chronic HIV infection and cocaine self-administration
慢性艾滋病毒感染和可卡因自我给药期间的单细胞转录组和表观基因组变化
- 批准号:
10629335 - 财政年份:2022
- 资助金额:
$ 38.14万 - 项目类别:
Single cell transcriptomic and epigenomic changes during chronic HIV infection and cocaine self-administration
慢性艾滋病毒感染和可卡因自我给药期间的单细胞转录组和表观基因组变化
- 批准号:
10454708 - 财政年份:2022
- 资助金额:
$ 38.14万 - 项目类别:
Single cell brain transcriptome changes during chronic HIV infection and opiate use in conventional mice
传统小鼠慢性艾滋病毒感染和阿片类药物使用期间单细胞脑转录组的变化
- 批准号:
10405624 - 财政年份:2021
- 资助金额:
$ 38.14万 - 项目类别:
Single cell brain transcriptome changes during chronic HIV infection and opiate use in conventional mice
传统小鼠慢性艾滋病毒感染和阿片类药物使用期间单细胞脑转录组的变化
- 批准号:
10594562 - 财政年份:2021
- 资助金额:
$ 38.14万 - 项目类别:
Single cell brain transcriptome changes during chronic HIV infection and opiate use in conventional mice
传统小鼠慢性艾滋病毒感染和阿片类药物使用期间单细胞脑转录组的变化
- 批准号:
10220584 - 财政年份:2021
- 资助金额:
$ 38.14万 - 项目类别:
Role for Circular RNAs in Compulsive Cocaine Intake
环状 RNA 在强迫性可卡因摄入中的作用
- 批准号:
10533296 - 财政年份:2019
- 资助金额:
$ 38.14万 - 项目类别:
相似国自然基金
Agonist-GPR119-Gs复合物的结构生物学研究
- 批准号:32000851
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
相似海外基金
S1PR1 agonistによる脳血液関門制御を介した脳梗塞の新規治療法開発
S1PR1激动剂调节血脑屏障治疗脑梗塞新方法的开发
- 批准号:
24K12256 - 财政年份:2024
- 资助金额:
$ 38.14万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
AHR agonistによるSLE皮疹の新たな治療薬の開発
使用 AHR 激动剂开发治疗 SLE 皮疹的新疗法
- 批准号:
24K19176 - 财政年份:2024
- 资助金额:
$ 38.14万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
- 批准号:
10578068 - 财政年份:2023
- 资助金额:
$ 38.14万 - 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
- 批准号:
10933287 - 财政年份:2023
- 资助金额:
$ 38.14万 - 项目类别:
Targeting breast cancer microenvironment with small molecule agonist of relaxin receptor
用松弛素受体小分子激动剂靶向乳腺癌微环境
- 批准号:
10650593 - 财政年份:2023
- 资助金额:
$ 38.14万 - 项目类别:
AMPKa agonist in attenuating CPT1A inhibition and alcoholic chronic pancreatitis
AMPKa 激动剂减轻 CPT1A 抑制和酒精性慢性胰腺炎
- 批准号:
10649275 - 财政年份:2023
- 资助金额:
$ 38.14万 - 项目类别:
Investigating mechanisms underpinning outcomes in people on opioid agonist treatment for OUD: Disentangling sleep and circadian rhythm influences on craving and emotion regulation
研究阿片类激动剂治疗 OUD 患者结果的机制:解开睡眠和昼夜节律对渴望和情绪调节的影响
- 批准号:
10784209 - 财政年份:2023
- 资助金额:
$ 38.14万 - 项目类别:
A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy volunteers to assess safety, pharmacokinetics, and transient biomarker changes by the ABCA1 agonist CS6253
在男性和女性健康志愿者中进行的一项随机双盲安慰剂对照 1 期 SAD 研究,旨在评估 ABCA1 激动剂 CS6253 的安全性、药代动力学和短暂生物标志物变化
- 批准号:
10734158 - 财政年份:2023
- 资助金额:
$ 38.14万 - 项目类别:
A novel nanobody-based agonist-redirected checkpoint (ARC) molecule, aPD1-Fc-OX40L, for cancer immunotherapy
一种基于纳米抗体的新型激动剂重定向检查点 (ARC) 分子 aPD1-Fc-OX40L,用于癌症免疫治疗
- 批准号:
10580259 - 财政年份:2023
- 资助金额:
$ 38.14万 - 项目类别:
Identification and characterization of a plant growth promoter from wild plants: is this a novel plant hormone agonist?
野生植物中植物生长促进剂的鉴定和表征:这是一种新型植物激素激动剂吗?
- 批准号:
23K05057 - 财政年份:2023
- 资助金额:
$ 38.14万 - 项目类别:
Grant-in-Aid for Scientific Research (C)